| 17/12/24 | 07:00:01 | 17 Dec 2024 | | Diaceutics Wins New $5.1m Contract |
| 10/12/24 | 15:14:19 | 10 Dec 2024 | | Holding(s) in Company |
| 05/12/24 | 07:00:16 | 5 Dec 2024 | | Awarded UK Research Institute Grant Funding of £1m |
| 03/12/24 | 14:24:00 | 3 Dec 2024 | | Total Voting Rights |
| 28/11/24 | 07:00:06 | 28 Nov 2024 | | Expansion of US Commercial Activities |
| 05/11/24 | 07:00:02 | 5 Nov 2024 | | Capital Markets Webinar |
| 04/11/24 | 07:00:08 | 4 Nov 2024 | | Holding(s) in Company |
| 30/10/24 | 14:58:15 | 30 Oct 2024 | | PDMR Shareholding/Share Incentive Plan |
| 29/10/24 | 10:27:39 | 29 Oct 2024 | | Board Change Update |
| 25/10/24 | 07:00:07 | 25 Oct 2024 | | Issue of Share Options/PDMR Shareholdings |
| 24/10/24 | 12:53:08 | 24 Oct 2024 | | Cancellation of Share Premium Account |
| 15/10/24 | 07:00:09 | 15 Oct 2024 | | Diaceutics Announces Key Leadership Appointment |
| 07/10/24 | 13:19:11 | 7 Oct 2024 | | Holding(s) in Company |
| 07/10/24 | 07:00:07 | 7 Oct 2024 | | Block Listing Return |
| 02/10/24 | 07:00:07 | 2 Oct 2024 | | PDMR Shareholding/Share Incentive Plan |
| 01/10/24 | 07:00:10 | 1 Oct 2024 | | Board Changes |
| 17/09/24 | 07:00:07 | 17 Sept 2024 | | H1 2024 Results - Continued Performance & Growth |
| 09/09/24 | 07:00:10 | 9 Sept 2024 | | Notice of Results & Presentations |
| 02/09/24 | 07:00:10 | 2 Sept 2024 | | Appointment of Nominated Adviser and Broker |
| 30/08/24 | 15:45:00 | 30 Aug 2024 | | PDMR Shareholding/Share Incentive Plan |
| 27/08/24 | 07:00:07 | 27 Aug 2024 | | Diaceutics Launches Enhanced Rare-Disease Offering |
| 19/08/24 | 07:00:11 | 19 Aug 2024 | | Enterprise Partnership and Launch of PMx |
| 05/08/24 | 07:00:03 | 5 Aug 2024 | | Presenting at Canaccord Genuity Growth Conference |
| 29/07/24 | 18:09:48 | 29 Jul 2024 | | PDMR Shareholding/SIP and TVR |
| 29/07/24 | 07:00:08 | 29 Jul 2024 | | Issue of Share Options/PDMR Shareholdings |
| 23/07/24 | 07:05:00 | 23 Jul 2024 | | Board Changes |
| 23/07/24 | 07:00:06 | 23 Jul 2024 | | Revenue growth of 24% in H1 with 55% now recurring |
| 11/07/24 | 07:00:10 | 11 Jul 2024 | | Senior Management Appointments |
| 01/07/24 | 07:00:08 | 1 Jul 2024 | | PDMR Shareholding/SIP and Total Voting Rights |
| 24/06/24 | 13:15:48 | 24 Jun 2024 | | Result of AGM |
| 13/06/24 | 07:00:11 | 13 Jun 2024 | | "Precision Medicine in Oncology " Virtual Event |
| 06/06/24 | 07:00:04 | 6 Jun 2024 | | Diaceutics - Capital Markets Event |
| 29/05/24 | 08:00:00 | 29 May 2024 | | Notice of AGM and Posting of Annual Report |
| 28/05/24 | 07:00:17 | 28 May 2024 | | Data to be Presented at 2024 ASCO Annual Meeting |
| 24/05/24 | 15:01:39 | 24 May 2024 | | PDMR Shareholding/SIP and Total Voting Rights |
| 23/05/24 | 07:00:15 | 23 May 2024 | | Director / PDMR Shareholding |
| 21/05/24 | 07:00:09 | 21 May 2024 | | Revenue growth of 22% & order book growth of 57% |
| 16/05/24 | 07:00:09 | 16 May 2024 | | Two New Enterprise-Wide Engagements |
| 14/05/24 | 07:00:06 | 14 May 2024 | | Diaceutics - Capital Markets Event |
| 01/05/24 | 07:00:14 | 1 May 2024 | | Notice of Results & Presentations |
| 30/04/24 | 07:00:15 | 30 Apr 2024 | | PDMR Shareholding/SIP and TVR |
| 09/04/24 | 07:00:07 | 9 Apr 2024 | | Appointment of Amie Mc Neice as VP of Marketing |
| 05/04/24 | 13:40:02 | 5 Apr 2024 | | Block Listing Return |
| 03/04/24 | 07:00:10 | 3 Apr 2024 | | PDMR Shareholding/Share Incentive Plan |
| 02/04/24 | 07:00:13 | 2 Apr 2024 | | Director/PDMR/PCA Shareholding & TR1 |
| 21/03/24 | 07:00:14 | 21 Mar 2024 | | Significant upgrade to Diaceutics' DXRX platform |
| 19/03/24 | 07:00:12 | 19 Mar 2024 | | Diaceutics forms landmark industry Forum |
| 07/03/24 | 07:00:13 | 7 Mar 2024 | | Director/PDMR Shareholding |
| 01/03/24 | 09:00:19 | 1 Mar 2024 | | PDMR Shareholding / SIP and TVR |
| 27/02/24 | 07:00:09 | 27 Feb 2024 | | Expanded lab network and data capabilities |
